|
|||||
|
|||||
Hello Nature readers, |
|||||
![]() |
|||||
This stunning image of the Trifid Nebula (top right) and the Lagoon Nebula combines 678 separate images taken by the Vera C. Rubin Observatory. (NSF-DOE Vera C. Rubin Observatory) | |||||
The universe as we’ve never seen itThe Vera C. Rubin Observatory in Chile has unveiled the first images taken using its 3,200 megapixel digital camera — the largest in the world. The images were put together mainly for aesthetic impact and to showcase the camera’s prowess, so they’re quite different to the ‘data products’ astronomers use for research, says the observatory’s Sandrine Thomas. Instead, they’re a reminder of what drives astronomers in the first place. “We go into astronomy because we like to look at the sky — and at the beauty of it,” she says. Nature | 4 min read |
|||||
Why grant success begets future fundingA study including data from more than 100,000 grant applications has revealed some of the underlying causes of the ‘Matthew effect’ — a phenomenon describing how scientists that secure funding grants early in their career are more likely to do so again later. Mathematical modelling of data from funding programmes in four countries suggested that those who had early grant success applied more often for future grants than those who didn’t, which explained the difference between the two groups. A new model of funding that rewards “promising but previously unsuccessful applicants” could level the playing field, says social scientist and study co-author Vincent Traag. Nature | 5 min readReference: Figshare preprint (not peer reviewed) |
|||||
Learning from animal ‘super healers’Axolotls can rebuild entire limbs and brain parts, zebrafish can mend broken spinal cords and green anole lizards can fabricate new tails. Scientists are taking what they have learnt about the regenerative powers of these and other animals and applying that knowledge to human cells, thanks to advances in genomics, proteomics and imaging at the level of the single cell. “I would love to see this go all the way to therapy,” says Mayssa Mokalled, who studies tissue regeneration and stem-cell biology. Nature | 3 min read |
|||||
Too many PhDs? Glut spurs calls for reform“The numbers are massive, and they keep growing,” says higher-education researcher Hugo Horta, speaking of the surge in doctoral students in China. Students enrolled in PhD programmes there have doubled in recent years, from around 300,000 in 2013 to more than 600,000 in 2023 — but the number of jobs in academia has not kept pace. For PhD holders in the United States, Australia and the United Kingdom, non-academic jobs are also increasingly becoming the norm. But that’s not necessarily bad news: a 2023 study of PhD graduates in the UK found that more than 90% were happy with their career. Nature | 5 min read |
|||||
|
|||||
How medical AI can tarnish patient dataMachine-learning systems that predict patient outcomes are only as good as the data the systems are trained on. If they are deployed carelessly, their very successes can contaminate the data, argues health-AI researcher Akhil Vaid. For example, if a machine catches early signs of sepsis and doctors treat it, “this creates a ‘contaminated association’ in the data, in which warning signs of sepsis seem to lead to good outcomes”, writes Vaid. One solution is to preserve ‘clean data’ at institutions where predictive models are not used. But this raises serious ethical questions, because it involves withholding potentially beneficial AI tools from some patients. Nature | 11 min read |
|||||
The long road to lenacapavirA new kind of drug to prevent HIV has been approved by the US Food and Drug Administration: lenacapavir, which disrupts the proteins that form the virus’s capsid shell. Unlike existing pre-exposure prophylaxis (PrEP) regimens, which involve taking a daily pill, lenacapavir need only be injected every six months. Last July, attendees at the 2024 AIDS Conference in Munich broke out in tears and applause as they welcomed the blockbuster news that, in a trial in women in Africa, lenacapavir provided 100% protection against HIV. But “the project almost died multiple times”, says virologist Stephen Yant, who helped develop the drug at pharma company Gilead Sciences. Science | 8 min readRead more: Trump blew up the global fight against AIDS. Can it recover? (Nature | 12 min read, from April) |
|||||
What quantum tech really looks likeIt’s International Women In Engineering Day and the International Year of Quantum — the ideal moment to hear from female engineers about the impact of quantum technologies on their fields. From renewable energy to the quantum internet, eight researchers explore possible paths towards a quantum future. Communications Engineering | 19 min read |
|||||
|
|||||
![]() |
|||||
Geomicrobiologist James Bradley has been studying microbial life on the Norwegian island of Svalbard for more than a decade. “With everything that we’ve discovered about ice microbes, we began to wonder whether an active microbial community could flourish in a similarly cold and nutrient-scarce environment: the atmosphere,” he says. “If we do find that the atmosphere hosts microbes that can live and grow there, without any connection to the ground, this would constitute the discovery of a new ecosystem — one that could be considered, by area, to be the largest on Earth.” (Nature | 3 min read) (Jacopo Pasotti for Nature) | |||||
Quote of the day“It’s not for a lot of people. But if it’s for you it’s really for you.”Anna Dhody, the former curator of the Mütter museum of medical specimens in Philadelphia, had a front-row seat at the debate over how the institution should balance the passion of its devotees with the ethically questionable provenance of its collection. (The New Yorker | 24 min read) |
|||||
|
|||||
|
|||||
|
|||||
Free newsletters from NatureWant more? Update your preferences to sign up to our other Nature Briefing newsletters:
|
|||||
Access Nature and 54 other Nature journals
Nature+ is our most affordable 30-day subscription, giving you online access to a wide range of specialist Nature Portfolio journals, including Nature. |
|||||
|
|||||
You received this newsletter because you subscribed with the email address: monia@podam.pl Please add briefing@nature.com to your address book. Enjoying this newsletter? You can use this form to recommend it to a friend or colleague — thank you! Had enough? To unsubscribe from this Briefing, but keep receiving your other Nature Briefing newsletters, please update your subscription preferences. To stop all Nature Briefing emails forever, click here to remove your personal data from our system. Fancy a bit of a read? View our privacy policy. Forwarded by a friend? Get the Briefing straight to your inbox: subscribe for free. Want to master time management, protect your mental health and brush up on your skills? Sign up for our free short e-mail series for working scientists, Back to the lab. Get more from Nature: Register for free on nature.com to sign up for other newsletters specific to your field and email alerts from Nature Portfolio journals. Would you like to read the Briefing in other languages? 关注Nature Portfolio官方微信订阅号,每周二为您推送Nature Briefing精选中文内容——自然每周简报。 Nature Portfolio | The Springer Nature Campus, 4 Crinan Street, London, N1 9XW, United Kingdom Nature Portfolio, part of Springer Nature. |